WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia: The Great Peptide Cash Grab Has Begun — Warptech Lab News

Storia in 13 fonti

The Great Peptide Cash Grab Has Begun

The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.

Raccontata da

independent.co.uk

statnews.com+1 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

wired.comStai leggendo2 g fa

The Great Peptide Cash Grab Has Begun

The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.

Timeline cronologica

lunedì 20 luglio 2026·fortune.com
The FDA’s peptide vote could create telehealth's next multibillion-dollar market | Fortune
As regulators weigh whether pharmacies can legally compound wellness peptides, companies are preparing for a repeat of the GLP-1 boom—only this time with even murkier science.
martedì 21 luglio 2026·forbes.com
FDA’s Review Of Peptides Signals A Growing Public Health Challenge
A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back their approval for legal compounding.

3 g fa

The FDA’s peptide vote could create telehealth's next multibillion-dollar market | Fortune

As regulators weigh whether pharmacies can legally compound wellness peptides, companies are preparing for a repeat of the GLP-1 boom—only this time with even murkier science.

Leggi questa versione → originale

thehindu.com20 h fa

What's the deal with peptides? The hyped market under U.S. review

Explore the controversial rise of peptides, their FDA review, and concerns over safety and clinical evidence in wellness trends.

Leggi questa versione → originale

forbes.com2 g fa

Peptides May Soon Be Legal. These Companies Are Ready To Cash In

With an FDA panel expected to recommend legal production of as many as seven peptides this week, compounding pharmacies and telehealth companies are preparing for the coming bonanza.

Leggi questa versione → originale

cbc.ca1 g fa

U.S. FDA panel to review 7 peptides amid growing popularity | CBC News

U.S. FDA advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if regulators decline to expand access, industry participants say consumer demand is likely to…

Leggi questa versione → originale

aljazeera.com1 g fa

US regulators to weigh controversial peptides backed by RFK Jr

FDA has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-ageing.

Leggi questa versione → originale

martedì 21 luglio 2026·

wired.com

The Great Peptide Cash Grab Has Begun

The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.

mercoledì 22 luglio 2026·

npr.org

Peptides get their regulatory closeup

A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized pharmacies should be allowed to make some popular…

mercoledì 22 luglio 2026·

forbes.com

Peptides May Soon Be Legal. These Companies Are Ready To Cash In

With an FDA panel expected to recommend legal production of as many as seven peptides this week, compounding pharmacies and telehealth companies are preparing for the coming…

mercoledì 22 luglio 2026·

forbes.com

FDA Set To Review Safety And Access To Peptides: What You Need To Know

An FDA panel is reviewing seven peptides for potential approval, sparking concerns about their widespread use in compounding pharmacies and the gray market.

mercoledì 22 luglio 2026·

cbc.ca

U.S. FDA panel to review 7 peptides amid growing popularity | CBC News

U.S. FDA advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if regulators decline to expand access, industry…

mercoledì 22 luglio 2026·

cnn.com

The future of peptides in the US is about to become clearer. Here’s what you should know | CNN

A little-known advisory group to the US Food and Drug Administration will meet this week to mull over whether to ease restrictions on certain peptides. The injectables are popular…

mercoledì 22 luglio 2026·

aljazeera.com

US regulators to weigh controversial peptides backed by RFK Jr

FDA has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-ageing.

giovedì 23 luglio 2026·

npr.org

FDA panel considers easing peptide restrictions

Advisers to the Food and Drug Administration are weighing the evidence for seven different peptides. Favorable votes would pave the way for easier access.

giovedì 23 luglio 2026·

apnews.com

FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers

Federal health advisers are meeting to review a group of controversial chemicals called peptides. The unapproved injections have become a popular wellness trend, promoted by…

giovedì 23 luglio 2026·

independent.co.uk

FDA reviews peptide injections favored by RFK Jr. and wellness influencers

Federal health advisers are meeting to review a group of controversial chemicals called peptides

giovedì 23 luglio 2026·

iol.co.za

What's the deal with peptides? The hyped market under US review

The substances under review -- including BPC-157, TB-500 and Semax -- are among those Joe Biden's administration restricted from compounding, notably over lack of human clinical…

giovedì 23 luglio 2026·

thehindu.com

What's the deal with peptides? The hyped market under U.S. review

Explore the controversial rise of peptides, their FDA review, and concerns over safety and clinical evidence in wellness trends.

giovedì 23 luglio 2026·

statnews.com

FDA staff and peptide enthusiasts set to clash at advisory panel

FDA advisers are set to consider whether allowing compounding pharmacies to offer largely unproven peptides is a safer bet than the gray-market versions now in use.

giovedì 23 luglio 2026·

eu.usatoday.com

What are peptides? The chemicals touted by RFK Jr., explained

The Food and Drug Administration is discussing whether unapproved peptides should be allowed in certain compounded prescription drugs. What are they?

giovedì 23 luglio 2026·

fortune.com

RFK Jr. calls himself a 'big fan,' so does Joe Rogan. Now an FDA panel is reviewing half a dozen peptides | Fortune

FDA scientists found only rat data on the seven peptides Kennedy's panel votes on this week — and seven advisers sell the products themselves.

giovedì 23 luglio 2026·

independent.co.uk

FDA panel backs peptide drug boosted by Joe Rogan

‘I’m a big fan of peptides; I’ve used them myself and used them with really good effect,’ the Secretary told Joe Rogan in February

venerdì 24 luglio 2026·

wired.com

An FDA Panel Just Endorsed These Unproven Peptides

Outside experts—some with a vested interest in peptides—recommended adding a number of the amino acids to the FDA's bulk list, including the “Wolverine stack” touted by Joe Rogan…